| Literature DB >> 35476123 |
Raymond Li1, Kate Curtis2, Connie Van2, Syed Tabish Razi Zaidi3, Chin Yen Yeo4, Christina Arun Kali4, Mithila Zaheen4, Grace Therese Moujalli4, Ronald Castelino2,4.
Abstract
PURPOSE: Adverse drug reaction (ADR) underreporting is highly prevalent across the world. This study aimed to identify factors associated with ADR reporting and map these to a behavioural change framework to help inform future interventions designed to improve ADR underreporting.Entities:
Keywords: Adverse drug reactions; Pharmacovigilance; Reporting; Theoretical domains framework
Mesh:
Year: 2022 PMID: 35476123 PMCID: PMC9043508 DOI: 10.1007/s00228-022-03326-x
Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN: 0031-6970 Impact factor: 3.064
Characteristics of respondents by healthcare professional type
| 41 (30.8) | 76 (57.1) | 16 (12.0) | 133 | ||
| 3.0 (1.0–5.5) | 8.0 (3.0–14.75) | 5.0 (1.5–10.75) | 5 (2–12) | ||
| 40 (39–42.5) | 40 (38–40) | 40 (38–40) | 40 (38–40) | ||
| Undergraduate (%) | 39.0 | 50.0 | 43.8 | 45.9 | |
| Postgraduate (%) | 61.0 | 50.0 | 56.3 | 54.1 | |
| Yes (%) | 41.5 | 76.3 | 75.0 | 65.4 | < 0.001a |
| No (%) | 58.5 | 23.7 | 25.0 | 34.6 | < 0.001b |
| Yes (%) | 36.6 | 72.4 | 100 | 64.7 | < 0.001a |
| No (%) | 63.4 | 27.6 | 0.0 | 35.3 | < 0.001b |
| Yes (%) | 22.0 | 36.8 | 43.7 | 34.6 | 0.013a |
| No (%) | 78.0 | 63.2 | 56.3 | 65.4 | |
| Yes (%) | 2.4 | 3.9 | 18.8 | 5.3 | n.s |
| No (%) | 97.6 | 96.1 | 81.2 | 94.7 | |
| Yes (%) | 7.3 | 17.1 | 25.0 | 15.0 | n.s |
| No (%) | 92.7 | 82.9 | 75.0 | 85.0 | |
| Yes (%) | 73.2 | 59.2 | 81.3 | 66.2 | n.s |
| No (%) | 26.8 | 40.8 | 18.8 | 33.8 | |
| Yes (%) | 46.3 | 31.6 | 75.0 | 41.4 | 0.001c |
| No (%) | 53.7 | 68.4 | 25.0 | 58.6 |
Significance value was set at 0.017 after applying the Bonferroni correction
n.s. not significant
aMedical officer vs pharmacist
bMedical officer vs nurse
cNurse vs pharmacist
Factors associated with healthcare professional reporting of ADR
| Know how to report ADR to TGA | 86 | 47 | 3.42 (1.55–7.61) | 3.34 (1.49–7.46) | 0.003 |
| Received training on ADR reporting | 46 | 87 | 2.60 (1.25–5.42) | 2.72 (1.29–5.77) | 0.009 |
| Awareness of TGA black triangle scheme | 7 | 126 | 9.43 (1.10–80.7) | 9.25 (0.35–55.8) | 0.25 |
| Subscribed to receive TGA safety alerts | 20 | 113 | 1.51 (0.58–3.92) | 1.36 (0.51–3.67) | 0.54 |
| Encountered ADR in clinical practice | 88 | 45 | 10.5 (3.79–29.2) | 10.3 (3.59–29.4) | < 0.001 |
^results were adjusted for no. years of clinical practice, no. of hours per week, and highest qualification
Perspectives of medical officers, nurse, and pharmacists towards ADR reporting (1–5 Likert scale)
| Reporting ADRs is important for patient care (beliefs about consequences) | 5 (4–5) | 4 (4–5) | 5 (4–5) | 5 (4–5) |
| Reporting ADRs should be mandatory for HCPs (behavioural regulation) | 5 (4–5) | 4 (4–5) | 5 (4–5) | 4.5 (4–5) |
| I have a professional obligation to report ADRs (social/professional role and identity) | 5 (4–5) | 4 (4–5) | 5 (4–5) | 5 (4–5) |
| The safety profile of medicines is well characterized by the time it is marketed (knowledge) | 4 (3–4) | 3 (3–4) | 4 (3–5) | 3 (2–4) |
| I’m interested in reading about ADRs in medical literature (reinforcement) | 4 (3–5) | 4 (3–4) | 4 (3–5) | 4.5 (4–5) |
| There was an incentive (reinforcement) | 3 (3–4) | 3 (2–4) | 3 (3–4) | 3 (2–4) |
| There was an electronic tool that automatically populates information from existing datasets (environment context and resources) | 5 (4–5) | 4 (4–5) | 5 (4–5) | 5 (4–5) |
| I’m mandated to report and there is a consequence if I don’t (beliefs about consequences) | 4 (3–4) | 4 (3–4.5) | 4 (3–4) | 4 (3–4.75) |
| There was a hospital protocol mandating ADR reporting (behavioural regulation) | 4 (3–5) | 4 (3–4) | 4 (3–4.75) | 4 (4–5) |
| I see that there are other HCPs reporting ADRs (social influences) | 4 (4–5) | 4 (4–4) | 4 (3–5) | 4 (3–5) |
| There was a reminder (environment context and resources) | 4 (3–4) | 4 (3–4) | 4 (3–4) | 4 (2.25–5) |
| It was serious and unexpected (beliefs about consequences) | 5 (4–5) | 5 (4–5) | 4 (4–5) | 5 (4–5) |
| It was for a new medicine (intention) | 4 (3–5) | 4 (4–5) | 4 (3–5) | 5 (4–5) |
| It has a strong causal association with the medicine (beliefs about consequences) | 4 (3–5) | 4 (4–5) | 4 (3–5) | 4 (3.25–5) |
| There is someone monitoring our ADR reporting (behavioural regulation) | 4 (3–4.5) | 4 (3–4) | 4 (3–4) | 4 (3.25–5) |
| I receive an acknowledgement (reinforcement) | 4 (3–4) | 4 (3–4) | 4 (3–4) | 3 (3–4) |
| I don’t have the time (environment context and resources) | 3 (2–4) | 4 (2.5–4) | 3 (2–4) | 4 (2.25–4) |
| I fear there may be legal repercussions (beliefs about consequences) | 2 (2–3) | 2 (2–3) | 3 (2–3) | 2 (1–2) |
| There are no results or actions taken based on ADRs I report (beliefs about consequences) | 3 (2–4) | 3 (2–4) | 3 (2–4) | 3 (2–4) |
| I forget to report at the time (memory, attention, and decision processes) | 3 (2–4) | 3 (2–4) | 3 (2–4) | 4 (3–4) |
| It was non-serious and expected (knowledge) | 3 (2–4) | 4 (3–4) | 3 (2–4) | 4 (3–4) |
| I don’t have enough information to warrant a report (environment context and resources) | 3 (3–4) | 3 (3–4) | 3 (2–4) | 4 (2.25–4) |
| I don’t know how to report (skills) | 3 (2–4) | 4 (3–4) | 3 (2–4) | 2 (2–3) |
| I’m uncertain of the causal relationship (knowledge) | 3 (3–4) | 4 (3–4) | 3 (2–4) | 3 (2.25–4) |
| I would rather have it published in the medical literature (intentions) | 3 (2–3) | 3 (3–4) | 3 (2–3) | 2 (1–2.75) |
| I don’t know when I’m supposed to (knowledge) | 3 (–4) | 4 (3–4) | 3 (2–4) | 2 (1.25–3) |
| It won’t make a difference (optimism, beliefs about consequences) | 3 (2–3) | 3 (2–4) | 3 (2–3) | 2 (1–3.75) |
| My colleagues don’t (social influence) | 3 (2–3) | 3 (2–4) | 3 (2–3) | 2 (1–3.75) |
| It would cause stress and burnout in my workload (emotion) | 3 (2–4) | 3 (2–4) | 3 (2–4) | 2.5 (1.25–3.75) |
| I have been encouraged not to (social influence) | 2 (1–3) | 2 (1–3) | 2 (2–3) | 2 (1–2) |
IQR interquartile range
Categorization of qualitative data
Quantitative and qualitative results mapped to the TDF to identify target domains that inform future interventions to improve ADR reporting
65.7% know how to report ADRs to the hospital safety committee 64.9% know how to report ADRs to the TGA 35.1% have received training on ADR reporting | Providing education to drive knowledge/awareness of ADR reporting Provide training on ADR reporting process Uncertain of causal relationship to warrant ADR report Non-serious ADRs do not need to be reported | Y | |
| N | |||
| I have a professional obligation to report ADRs (median score 5 out of 5) | N | ||
| N | |||
| N | |||
More likely to report if the ADR was serious and unexpected (median score 5 out of 5) Reporting ADRs is important for patient care (median score 5 out of 5) | Fear of legal repercussions for reporting ADRs | Y | |
Providing acknowledgement/feedback for reported ADRs Incentivize the reporting of ADRs | N | ||
| N | |||
| N | |||
Forget to report ADRs | N | ||
| More likely to report if there was an electronic tool that automates ADR reporting (median score 5 out of 5) | Automate the reporting process Use electronic tools/software to assist ADR reporting Creating reminders to assist ADR reporting Lack of time to report ADRs Make ADR reporting easier High workload/lack of resources | Y | |
Provide encouragement for colleagues to report ADRs | N | ||
| N | |||
| Reporting ADRs should be mandatory for HCPs (median score 5 out of 5) | Make ADR reporting mandatory through protocols | N |